RAC Regulatory Frameworks 1 — Questions and Answers
Question 1: Which U.S. law established the FDA’s authority to oversee drug safety?
- Kefauver-Harris Amendment
- Drug Listing Act
- Food, Drug, and Cosmetic Act (Correct answer)
- Prescription Drug Marketing Act
Correct answer: Food, Drug, and Cosmetic Act
The Federal Food, Drug, and Cosmetic (FD&C) Act, passed in 1938, is the foundational law that granted the FDA its authority to regulate drugs, food, and cosmetics. It mandated that new drugs be proven safe before marketing and established requirements for labeling. While subsequent amendments like Kefauver-Harris added efficacy requirements, the FD&C Act initially established the FDA's core oversight of drug safety.
Question 2: What is the purpose of the ICH guidelines?
- Local drug pricing regulation
- Standardize preclinical animal testing only
- International harmonization of drug regulations (Correct answer)
- Healthcare facility inspections
Correct answer: International harmonization of drug regulations
The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) brings together regulatory authorities and the pharmaceutical industry from various regions. Its purpose is to achieve greater harmonization in the interpretation and application of technical guidelines and requirements for drug registration. This reduces duplication of testing and speeds up the availability of new medicines globally.
Question 3: What is a key responsibility of regulatory affairs professionals?
- Oversee daily operations
- Develop clinical trial protocols
- Ensure regulatory compliance (Correct answer)
- Manage hospital workflows
Correct answer: Ensure regulatory compliance
Regulatory affairs professionals are responsible for ensuring that their company's products (drugs, devices, biologics) comply with all applicable laws, regulations, and guidelines set by regulatory bodies worldwide. This involves preparing and submitting regulatory documents, interacting with agencies, and advising internal teams on compliance strategies throughout the product lifecycle. Their role is critical for market access and product integrity.
Question 4: Which document is required to begin clinical trials in the U.S.?
- New Drug Application (NDA)
- Biologics License Application (BLA)
- Investigational New Drug (IND) (Correct answer)
- Medical Device Reporting (MDR)
Correct answer: Investigational New Drug (IND)
Before a pharmaceutical company can begin clinical trials in humans in the U.S., it must submit an Investigational New Drug (IND) application to the FDA. The IND provides comprehensive information on the drug's composition, manufacturing, and results from preclinical (animal) studies, along with the proposed clinical trial protocols. The FDA reviews the IND to ensure the safety of human subjects before trials can proceed.
Question 5: What is the role of the European Medicines Agency (EMA)?
- Approve U.S. drugs
- Oversee food labeling
- Evaluate medicines in the European Union (Correct answer)
- Manage health insurance claims
Correct answer: Evaluate medicines in the European Union
The European Medicines Agency (EMA) is a decentralized agency of the European Union responsible for the scientific evaluation, supervision, and safety monitoring of medicines developed for use in the EU. It plays a central role in authorizing new medicines for the entire European market, ensuring they meet high standards of quality, safety, and efficacy.
Question 6: Which regulatory pathway expedites the review of drugs for serious conditions in the U.S.?
- ANDA
- Orphan Drug Act
- Fast Track designation (Correct answer)
- Hatch-Waxman Act
Correct answer: Fast Track designation
Fast Track designation is an FDA program designed to facilitate the development and expedite the review of drugs intended to treat serious conditions and fill an unmet medical need. This designation allows for more frequent communication with the FDA and, potentially, a rolling review of the application, aiming to get important new drugs to patients sooner.
Which U.S. law established the FDA’s authority to oversee drug safety?